Digital Therapeutics Market
Digital Therapeutics Market Study by Diabetes, Obesity, CVD, Respiratory Diseases, Smoking Cessation, and CNS Diseases for Patients, Providers, Payers, and Employers from 2024 to 2034
Analysis of Digital Therapeutics Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Digital Therapeutics Market Outlook (2024 to 2034)
The global digital therapeutics market size is forecast to expand at a CAGR of 22%, which will push the market value from US$ 8 billion in 2024 to US$ 58.7 billion by the end of 2034.
Digital therapeutics refers to the software and equipment that digitally store evidence-based therapeutic actions for illness prevention and management. Software and gadgets help treat a variety of mental health, diabetic, respiratory, and cardiovascular diseases. The rising global prevalence of chronic diseases such as diabetes, mental illness, cancer, and heart failure is driving up the demand for digital therapeutics and related technologies.
- The market for digital therapeutics in Mexico is projected to reach a value of US$ 2.8 billion by 2034-end.
Market players are focusing on research and development operations in order to produce innovative and advanced therapies for treating a variety of diseases. Digital therapeutics helps provide personalized prescriptions, regulate lifestyles and diets, track daily activities, and treat physical, mental, and behavioral health disorders.
New and technologically advanced therapies provide data-driven insights, reduce human error, boost customer satisfaction, and deliver a high-quality user experience, resulting in increased market demand for such treatment options. The digital therapeutics landscape is experiencing steady market growth with the rising need for diabetes diagnostics and management.
| Report Attributes | Details |
|---|---|
| Digital Therapeutics Market Size (2024E) | US$ 8 Billion |
| Projected Market Value (2034F) | US$ 58.7 Billion |
| Global Market Growth Rate (2024 to 2034) | 22% CAGR |
| China Market Value (2034F) | US$ 6.4 Billion |
| Canada Market Growth Rate (2024 to 2034) | 22.5% CAGR |
| North America Market Share (2024E) | 23.9% |
| East Asia Market Value (2034F) | US$ 13.6 Billion |
| Key Companies Profiled |
|
Don't Need a Global Report?
save 40%! on Country & Region specific reports
What are the Key Market Drivers for Digital Therapeutics?
“Increasing Number of Chronic Diseases Driving Health Consciousness”
One of the key market drivers for digital therapeutics is the growing prevalence of chronic diseases. Rapid urbanization has led to the prevalence of sedentary lifestyles. This is directly affecting the health of most populations. The United States healthcare system spends billions of dollars annually on providing care to patients suffering from chronic health conditions such as diabetes, high blood pressure, congestive heart failure, and chronic obstructive pulmonary disease.
- According to the Centers for Disease Control and Prevention, six out of every ten Americans have at least one chronic health condition, and four out of every ten Americans have at least two chronic conditions. As a result, they account for US$ 3.7 trillion in annual health care costs in the United States.
Healthcare organizations utilize evidence-based digital therapeutics to reduce the mounting costs associated with the care of an increasing number of patients with chronic health conditions.
In collaboration with iRhythm, Verily (subsidiary of Alphabet Inc.) developed a study watch with an irregular pulse monitor for continuous monitoring, big data analytics, and cloud-based machine learning to create innovative solutions for screening and monitoring atrial fibrillation (AFib).
What are the Obstacles Impeding Faster Market Expansion?
“Internet Hacking and Phishing Significant Threat to Market”
In relation to digital health matters, the appropriate legal basis for the processing of data is still unclear. Digital health transformation is a complex, expensive, and lengthy endeavor in which all parties' interests need to be reconciled. For digital therapeutics to be widely adopted, cybersecurity and data privacy must be considered. The fact that digital therapeutics solutions and services are delivered over the internet has increased the risk of unauthorized access and manipulation of the underlying data, compromising both patient health and trust in the products and services.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Country Wise Insights
Fact.MR, a market research and competitive intelligence provider, through its recently published industry analysis, asserts that North America is projected to hold 24.3% of the global market by 2034. Digital therapeutic providers have expanded their footprint to diverse regions such as Southeast Asia, Central and South America, and Australia. This expansion allows market players to effectively meet the rising global demand while diversifying their source of supply and reducing dependence on a single source.
What’s Driving Popularity of Digital Therapeutics in the United States?
“High Popularity of Access to Treatment from Comfort of Home”
| Attribute | United States |
|---|---|
| Market Value (2024E) | US$ 900 Million |
| Growth Rate (2024 to 2034) | 22.5% CAGR |
| Projected Value (2034F) | US$ 6.5 Billion |
Digital therapeutics is a new health discipline that makes use of digital and online health technologies to treat various medical and psychological conditions and are increasingly being embraced in the United States due to its convenience and accessibility factor.
Increasing popularity of digital therapeutics in the United States is due to the rising prevalence of chronic diseases such as diabetes, heart disease, and various forms of cancer. Digital therapeutics offer easy-to-use, cost-effective treatment options that can be accessed from the comfort of one's own home. It allows for personalized therapy, allowing patients to tailor their treatment to their specific needs. This level of personalization has been shown to increase patient engagement and adherence to treatment, which, in turn, improves outcomes.
Which Strategies are Fueling Market Expansion in China?
“Growing Awareness of Cost-Effective and At-Home Healthcare”
| Attribute | China |
|---|---|
| Market Value (2024E) | US$ 900 Million |
| Growth Rate (2024 to 2034) | 22% CAGR |
| Projected Value (2034F) | US$ 6.4 Billion |
Active formation of alliances and collaborations by leading market players is expected to drive the digital therapeutics industry growth in China. This is due to technological improvements, government backing, and the growing prevalence of chronic diseases in the country. Digital therapeutics providers are focusing on addressing the challenges presented by China's aging population and healthcare demands. Evidence-based software-delivered therapeutic interventions are playing a critical role in overcoming these challenges in this huge country.
Digital therapeutics market trends in China have influenced the focus on addressing challenges such as limited healthcare awareness among patients, geographical gaps in healthcare providers, immense pressures in market access, and difficulties in extending at-home patient management. Addressing these challenges and positioning for long-term support of clinical evidence is enabling the successful integration of digital therapeutics into China’s healthcare system to improve patient outcomes.
The market is also leveraging the rapid digital growth in areas such as e-commerce. While such rapid digital therapeutics market growth is exciting in the country, business models that offer returns are less understood. China's digital health evolution will be beneficial for market players in the long run.
Category-wise Insights
Digital therapeutics has a varied application for several ailments such as diabetes, obesity, CVD, respiratory diseases, smoking cessation, and CNS diseases. Out of these, digital therapeutics application in diabetes currently holds leading market share of 28% in 2024.
Which End User Accounts for a Leading Digital Therapeutics Market Share?
“Increasing Number of Patients Accessing Digital Therapeutic Solutions”
| Attribute | Patients |
|---|---|
| Segment Value (2024E) | US$ 3.6 Billion |
| Growth Rate (2024 to 2034) | 21.2% CAGR |
| Projected Value (2034F) | US$ 24.7 Billion |
Adoption of digital therapeutic solutions by patients themselves is leading to an increase in the market share of this segment. Patients are the primary users of therapeutic healthcare applications and programs, and their rapid adoption of digital therapeutics has led to this segment holding the leading market share. Convenience and accessibility of digital therapeutics, along with its ability to provide personalized and data-based therapeutic interventions makes this model more appealing to patients.
Why is Digital Therapeutics So Popular for Diabetes Care?
“Evidence-Based Therapeutic Treatments for Diabetes Driving Sales”
| Attribute | Diabetes |
|---|---|
| Segment Value (2024E) | US$ 2.3 Billion |
| Growth Rate (2024 to 2034) | 21.1% CAGR |
| Projected Value (2034F) | US$ 15.3 Billion |
Digital therapeutics provides patients with personalized therapeutic interventions with high-quality software programs to prevent, manage, or treat diabetes. The rise in the incidence of chronic ailments, especially diabetes, cardiac conditions, and obesity, is contributing to the growth of the segment in the digital therapeutics market. Another factor is the widespread awareness about the benefits of digital healthcare, especially in the wake of the pandemic. Understanding that managing or reversing diabetes through digital therapeutics is a better option has led to its increased adoption.
Digital diabetes management systems help patients improve self-management and control their condition. Lowering and keeping blood sugar low is one of the key challenges in the treatment of diabetes and increases the acceptance of these systems. Digital engagement plays an important role in providing adequate care for patients with type 1 and type 2 diabetes. A significant rise in the use of handheld and wearable devices for health monitoring is also fueling the sales of digital therapeutics for diabetes management.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Competitive Landscape
Key players in the digital therapeutics industry are Omada Health Inc, WellDoc Inc, 2Morrow Inc, Fitbit Inc, Noom Inc., Fitbit Inc., Canary Health, and Mango Health. Providers of digital therapeutics are increasingly innovating new methods to offer better and cost-effective healthcare services digitally by merging with other renowned producers.
- In 2023, Noom launched Noom Med, which is a new initiative that provides telehealth services and tailored psychological resources to assist individuals struggling with obesity in joining weight loss programs.
- In 2022, Fitbit Health Solutions announced a collaboration with Pretaa. This partnership aims to enhance the recovery process for Americans and their families dealing with substance abuse by integrating health and activity data into Pretaa’s app designed for substance abuse recovery.
Key Segments of Digital Therapeutics Market Research
-
By Application :
- Diabetes
- Obesity
- CVD
- Respiratory Diseases
- Smoking Cessation
- CNS Diseases
-
By End User :
- Patients
- Providers
- Payers
- Employers
-
By Region :
- North America
- Latin America
- Europe
- East Asia
- South Asia & Oceania
- Middle East & Africa
Table of Content
1. Executive Summary 1.1. Global Market Outlook 1.2. Summary of Statistics 1.3. Key Market Characteristics & Attributes 1.4. Fact.MR Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Risks and Trends Assessment 3.1. Risk Assessment 3.1.1. COVID-19 Crisis and Impact on Demand 3.1.2. COVID-19 Impact Benchmark with Previous Crisis 3.1.3. Impact on Market Value (US$ Mn) 3.1.4. Assessment by Key Countries 3.1.5. Assessment by Key Market Segments 3.1.6. Action Points and Recommendation for Suppliers 3.2. Key Trends Impacting the Market 3.3. Formulation and Product Development Trends 4. Market Background and Foundation Data Points 4.1. Global Market (US$ Mn) 4.2. Market Opportunity Assessment (US$ Mn) 4.2.1. Total Available Market 4.2.2. Serviceable Addressable Market 4.2.3. Serviceable Obtainable Market 4.3. Market Scenario Forecast 4.3.1. Demand in optimistic Scenario 4.3.2. Demand in Likely Scenario 4.3.3. Demand in Conservative Scenario 4.4. Investment Feasibility Analysis 4.4.1. Investment in Established Markets 4.4.1.1. In Short Term 4.4.1.2. In Long Term 4.4.2. Investment in Emerging Markets 4.4.2.1. In Short Term 4.4.2.2. In Long Term 4.5. Forecast Factors - Relevance & Impact 4.5.1. Top Companies Historical Growth 4.5.2. Global Market Growth 4.5.3. Adoption Rate, By Country 4.6. Market Dynamics 4.6.1. Market Driving Factors and Impact Assessment 4.6.2. Prominent Market Challenges and Impact Assessment 4.6.3. Market Opportunities 4.6.4. Prominent Trends in the Global Market & Their Impact Assessment 5. Key Success Factors 5.1. Manufacturers’ Focus on Low Penetration High Growth Markets 5.2. Banking on with Segments High Incremental Opportunity 5.3. Peer Benchmarking 6. Global Market Demand Analysis 2018-2023 and Forecast, 2024-2034 6.1. Historical Market Analysis, 2018-2023 6.2. Current and Future Market Projections, 2024-2034 6.3. Y-o-Y Growth Trend Analysis 7. Global Market Value Analysis 2018-2023 and Forecast, 2024-2034 7.1. Historical Market Value (US$ Mn) Analysis, 2018-2023 7.2. Current and Future Market Value (US$ Mn) Projections, 2024-2034 7.2.1. Y-o-Y Growth Trend Analysis 7.2.2. Absolute $ Opportunity Analysis 8. Global Market Analysis 2018-2023 and Forecast 2024-2034, By End-user 8.1. Introduction / Key Findings 8.2. Historical Market Size (US$ Mn) Analysis By End-user, 2018-2023 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End-user, 2024-2034 8.3.1. Patients 8.3.2. Providers 8.3.3. Payers 8.3.4. Employers 8.3.5. Others 8.4. Market Attractiveness Analysis By End-user 9. Global Market Analysis 2018-2023 and Forecast 2024-2034, By Application 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Mn) Analysis By Application, 2018-2023 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2024-2034 9.3.1. Diabetes 9.3.2. Obesity 9.3.3. CVD 9.3.4. Respiratory Diseases 9.3.5. Smoking Cessation 9.3.6. CNS Diseases 9.3.7. Others 9.4. Market Attractiveness Analysis By Application 10. Global Market Analysis 2018-2023 and Forecast 2024-2034, By Region 10.1. Introduction 10.2. Historical Market Size (US$ Mn) Analysis By Region, 2018-2023 10.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2024-2034 10.3.1. North America 10.3.2. Latin America 10.3.3. Europe 10.3.4. Asia Pacific 10.3.5. Middle East and Africa (MEA) 10.4. Market Attractiveness Analysis By Region 11. North America Market Analysis 2018-2023 and Forecast 2024-2034 11.1. Introduction 11.2. Pricing Analysis 11.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2023 11.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2024-2034 11.4.1. By Country 11.4.1.1. U.S. 11.4.1.2. Canada 11.4.1.3. Rest of North America 11.4.2. By End-user 11.4.3. By Application 11.5. Market Attractiveness Analysis 11.5.1. By Country 11.5.2. By End-user 11.5.3. By Application 12. Latin America Market Analysis 2018-2023 and Forecast 2024-2034 12.1. Introduction 12.2. Pricing Analysis 12.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2023 12.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2024-2034 12.4.1. By Country 12.4.1.1. Brazil 12.4.1.2. Mexico 12.4.1.3. Rest of Latin America 12.4.2. By End-user 12.4.3. By Application 12.5. Market Attractiveness Analysis 12.5.1. By Country 12.5.2. By End-user 12.5.3. By Application 13. Europe Market Analysis 2018-2023 and Forecast 2024-2034 13.1. Introduction 13.2. Pricing Analysis 13.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2023 13.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2024-2034 13.4.1. By Country 13.4.1.1. Germany 13.4.1.2. France 13.4.1.3. U.K. 13.4.1.4. Italy 13.4.1.5. Benelux 13.4.1.6. Nordic Countries 13.4.1.7. Rest of Europe 13.4.2. By End-user 13.4.3. By Application 13.5. Market Attractiveness Analysis 13.5.1. By Country 13.5.2. By End-user 13.5.3. By Application 14. Asia Pacific Market Analysis 2018-2023 and Forecast 2024-2034 14.1. Introduction 14.2. Pricing Analysis 14.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2023 14.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2024-2034 14.4.1. By Country 14.4.1.1. China 14.4.1.2. Japan 14.4.1.3. South Korea 14.4.1.4. Rest of Asia Pacific 14.4.2. By End-user 14.4.3. By Application 14.5. Market Attractiveness Analysis 14.5.1. By Country 14.5.2. By End-user 14.5.3. By Application 15. Middle East and Africa Market Analysis 2018-2023 and Forecast 2024-2034 15.1. Introduction 15.2. Pricing Analysis 15.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2023 15.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2024-2034 15.4.1. By Country 15.4.1.1. GCC Countries 15.4.1.2. South Africa 15.4.1.3. Turkey 15.4.1.4. Rest of Middle East and Africa 15.4.2. By End-user 15.4.3. By Application 15.5. Market Attractiveness Analysis 15.5.1. By Country 15.5.2. By End-user 15.5.3. By Application 16. Key Countries Market Analysis 2018-2023 and Forecast 2024-2034 16.1. Introduction 16.1.1. Market Value Proportion Analysis, By Key Countries 16.1.2. Global Vs. Country Growth Comparison 16.2. US Market Analysis 16.2.1. Value Proportion Analysis by Market Taxonomy 16.2.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2034 16.2.2.1. By End-user 16.2.2.2. By Application 16.3. Canada Market Analysis 16.3.1. Value Proportion Analysis by Market Taxonomy 16.3.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2034 16.3.2.1. By End-user 16.3.2.2. By Application 16.4. Mexico Market Analysis 16.4.1. Value Proportion Analysis by Market Taxonomy 16.4.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2034 16.4.2.1. By End-user 16.4.2.2. By Application 16.5. Brazil Market Analysis 16.5.1. Value Proportion Analysis by Market Taxonomy 16.5.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2034 16.5.2.1. By End-user 16.5.2.2. By Application 16.6. Germany Market Analysis 16.6.1. Value Proportion Analysis by Market Taxonomy 16.6.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2034 16.6.2.1. By End-user 16.6.2.2. By Application 16.7. France Market Analysis 16.7.1. Value Proportion Analysis by Market Taxonomy 16.7.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2034 16.7.2.1. By End-user 16.7.2.2. By Application 16.8. Italy Market Analysis 16.8.1. Value Proportion Analysis by Market Taxonomy 16.8.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2034 16.8.2.1. By End-user 16.8.2.2. By Application 16.9. BENELUX Market Analysis 16.9.1. Value Proportion Analysis by Market Taxonomy 16.9.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2034 16.9.2.1. By End-user 16.9.2.2. By Application 16.10. UK Market Analysis 16.10.1. Value Proportion Analysis by Market Taxonomy 16.10.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2034 16.10.2.1. By End-user 16.10.2.2. By Application 16.11. Nordic Countries Market Analysis 16.11.1. Value Proportion Analysis by Market Taxonomy 16.11.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2034 16.11.2.1. By End-user 16.11.2.2. By Application 16.12. China Market Analysis 16.12.1. Value Proportion Analysis by Market Taxonomy 16.12.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2034 16.12.2.1. By End-user 16.12.2.2. By Application 16.13. Japan Market Analysis 16.13.1. Value Proportion Analysis by Market Taxonomy 16.13.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2034 16.13.2.1. By End-user 16.13.2.2. By Application 16.14. South Korea Market Analysis 16.14.1. Value Proportion Analysis by Market Taxonomy 16.14.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2034 16.14.2.1. By End-user 16.14.2.2. By Application 16.15. GCC Countries Market Analysis 16.15.1. Value Proportion Analysis by Market Taxonomy 16.15.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2034 16.15.2.1. By End-user 16.15.2.2. By Application 16.16. South Africa Market Analysis 16.16.1. Value Proportion Analysis by Market Taxonomy 16.16.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2034 16.16.2.1. By End-user 16.16.2.2. By Application 16.17. Turkey Market Analysis 16.17.1. Value Proportion Analysis by Market Taxonomy 16.17.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2034 16.17.2.1. By End-user 16.17.2.2. By Application 16.17.3. Competition Landscape and Player Concentration in the Country 17. Market Structure Analysis 17.1. Market Analysis by Tier of Companies 17.2. Market Concentration 17.3. Market Share Analysis of Top Players 17.4. Market Presence Analysis 17.4.1. By Regional footprint of Players 17.4.2. Product footprint by Players 18. Competition Analysis 18.1. Competition Dashboard 18.2. Competition Benchmarking 18.3. Competition Deep Dive 18.3.1. Omada Health 18.3.1.1. Overview 18.3.1.2. Product Portfolio 18.3.1.3. Sales Footprint 18.3.1.4. Strategy Overview 18.3.2. WellDoc 18.3.2.1. Overview 18.3.2.2. Product Portfolio 18.3.2.3. Sales Footprint 18.3.2.4. Strategy Overview 18.3.3. Livongo Health, Inc. 18.3.3.1. Overview 18.3.3.2. Product Portfolio 18.3.3.3. Sales Footprint 18.3.3.4. Strategy Overview 18.3.4. Propeller Health 18.3.4.1. Overview 18.3.4.2. Product Portfolio 18.3.4.3. Sales Footprint 18.3.4.4. Strategy Overview 18.3.5. Fitbit Inc. 18.3.5.1. Overview 18.3.5.2. Product Portfolio 18.3.5.3. Sales Footprint 18.3.5.4. Strategy Overview 18.3.6. Canary Health 18.3.6.1. Overview 18.3.6.2. Product Portfolio 18.3.6.3. Sales Footprint 18.3.6.4. Strategy Overview 18.3.7. Mango Health 18.3.7.1. Overview 18.3.7.2. Product Portfolio 18.3.7.3. Sales Footprint 18.3.7.4. Strategy Overview 18.3.8. Noom, Inc. 18.3.8.1. Overview 18.3.8.2. Product Portfolio 18.3.8.3. Sales Footprint 18.3.8.4. Strategy Overview 18.3.9. Pear Therapeutics 18.3.9.1. Overview 18.3.9.2. Product Portfolio 18.3.9.3. Sales Footprint 18.3.9.4. Strategy Overview 18.3.10. 2Morrow, Inc. 18.3.10.1. Overview 18.3.10.2. Product Portfolio 18.3.10.3. Sales Footprint 18.3.10.4. Strategy Overview 19. Assumptions and Acronyms Used 20. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Value (US$ Mn), By End-user, 2018-2023
Table 02: Global Market Value (US$ Mn), By End-user, 2024-2034
Table 03: Global Market Value (US$ Mn), By Application, 2018-2023
Table 04: Global Market Value (US$ Mn), By Application, 2024-2034
Table 05: Global Market, By Region, 2018-2023
Table 06: Global Market, By Region, 2024-2034
Table 07: North America Market Value (US$ Mn), By End-user, 2018-2023
Table 08: North America Market Value (US$ Mn), By End-user, 2024-2034
Table 09: North America Market Value (US$ Mn), By Application, 2018-2023
Table 10: North America Market Value (US$ Mn), By Application, 2024-2034
Table 11: North America Market, By Country, 2018-2023
Table 12: North America Market, By Country, 2024-2034
Table 13: Latin America Market Value (US$ Mn), By End-user, 2018-2023
Table 14: Latin America Market Value (US$ Mn), By End-user, 2024-2034
Table 15: Latin America Market Value (US$ Mn), By Application, 2018-2023
Table 16: Latin America Market Value (US$ Mn), By Application, 2024-2034
Table 17: Latin America Market, By Country, 2018-2023
Table 18: Latin America Market, By Country, 2024-2034
Table 19: Europe Market Value (US$ Mn), By End-user, 2018-2023
Table 20: Europe Market Value (US$ Mn), By End-user, 2024-2034
Table 21: Europe Market Value (US$ Mn), By Application, 2018-2023
Table 22: Europe Market Value (US$ Mn), By Application, 2024-2034
Table 23: Europe Market, By Country, 2018-2023
Table 24: Europe Market, By Country, 2024-2034
Table 25: Asia Pacific Market Value (US$ Mn), By End-user, 2018-2023
Table 26: Asia Pacific Market Value (US$ Mn), By End-user, 2024-2034
Table 27: Asia Pacific Market Value (US$ Mn), By Application, 2018-2023
Table 28: Asia Pacific Market Value (US$ Mn), By Application, 2024-2034
Table 29: Asia Pacific Market, By Country, 2018-2023
Table 30: Asia Pacific Market, By Country, 2024-2034
Table 31: MEA Market Value (US$ Mn), By End-user, 2018-2023
Table 32: MEA Market Value (US$ Mn), By End-user, 2024-2034
Table 33: MEA Market Value (US$ Mn), By Application, 2018-2023
Table 34: MEA Market Value (US$ Mn), By Application, 2024-2034
Table 35: MEA Market, By Country, 2018-2023
Table 36: MEA Market, By Country, 2024-2034
Table 37: Global Market Incremental $ Opportunity, By End-user, 2018-2023
Table 38: Global Market Incremental $ Opportunity, By Application, 2024-2034
Table 39: Global Market Incremental $ Opportunity, By Region, 2024-2034
Table 40: North America Market Incremental $ Opportunity, By End-user, 2018-2023
Table 41: North America Market Incremental $ Opportunity, By Application, 2024-2034
Table 42: North America Market Incremental $ Opportunity, By Country, 2024-2034
Table 43: Latin America Market Incremental $ Opportunity, By End-user, 2018-2023
Table 44: Latin America Market Incremental $ Opportunity, By Application, 2024-2034
Table 45: Latin America Market Incremental $ Opportunity, By Country, 2024-2034
Table 46: Europe Market Incremental $ Opportunity, By End-user, 2018-2023
Table 47: Europe Market Incremental $ Opportunity, By Application, 2024-2034
Table 48: Europe Market Incremental $ Opportunity, By Country, 2024-2034
Table 49: Asia Pacific Market Incremental $ Opportunity, By End-user, 2018-2023
Table 50: Asia Pacific Market Incremental $ Opportunity, By Application, 2024-2034
Table 51: Asia Pacific Market Incremental $ Opportunity, By Country, 2024-2034
Table 52: MEA Market Incremental $ Opportunity, By End-user, 2018-2023
Table 53: MEA Market Incremental $ Opportunity, By Application, 2024-2034
Table 54: MEA Market Incremental $ Opportunity, By Country, 2024-2034
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Value (US$ Mn) and Year-on-Year Growth, 2018-2034
Figure 02: Global Market Absolute $ Historical Gain (2018-2023) and Opportunity (2024-2034), US$ Mn
Figure 03: Global Market Share, By End-user, 2024 & 2034
Figure 04: Global Market Y-o-Y Growth Projections, By End-user – 2024-2034
Figure 05: Global Market Attractiveness Index, By End-user – 2024-2034
Figure 06: Global Market Share, By Application, 2024 & 2034
Figure 07: Global Market Y-o-Y Growth Projections, By Application – 2024-2034
Figure 08: Global Market Attractiveness Index, By Application – 2024-2034
Figure 09: Global Market Share, By Region, 2024 & 2034
Figure 10: Global Market Y-o-Y Growth Projections, By Region – 2024-2034
Figure 11: Global Market Attractiveness Index, By Region – 2024-2034
Figure 12: North America Market Value (US$ Mn) and Year-on-Year Growth, 2018-2034
Figure 13: North America Market Absolute $ Opportunity Historical (2018-2023) and Forecast Period (2024-2034), US$ Mn
Figure 14: North America Market Share, By End-user, 2024 & 2034
Figure 15: North America Market Y-o-Y Growth Projections, By End-user – 2024-2034
Figure 16: North America Market Attractiveness Index, By End-user – 2024-2034
Figure 17: North America Market Share, By Application, 2024 & 2034
Figure 18: North America Market Y-o-Y Growth Projections, By Application – 2024-2034
Figure 19: North America Market Attractiveness Index, By Application – 2024-2034
Figure 20: North America Market Share, By Country, 2024 & 2034
Figure 21: North America Market Y-o-Y Growth Projections, By Country – 2024-2034
Figure 22: North America Market Attractiveness Index, By Country – 2024-2034
Figure 23: Latin America Market Value (US$ Mn) and Year-on-Year Growth, 2018-2034
Figure 24: Latin America Market Absolute $ Opportunity Historical (2018-2023) and Forecast Period (2024-2034), US$ Mn
Figure 25: Latin America Market Share, By End-user, 2024 & 2034
Figure 26: Latin America Market Y-o-Y Growth Projections, By End-user – 2024-2034
Figure 27: Latin America Market Attractiveness Index, By End-user – 2024-2034
Figure 28: Latin America Market Share, By Application, 2024 & 2034
Figure 29: Latin America Market Y-o-Y Growth Projections, By Application – 2024-2034
Figure 30: Latin America Market Attractiveness Index, By Application – 2024-2034
Figure 31: Latin America Market Share, By Country, 2024 & 2034
Figure 32: Latin America Market Y-o-Y Growth Projections, By Country – 2024-2034
Figure 33: Latin America Market Attractiveness Index, By Country – 2024-2034
Figure 34: Europe Market Value (US$ Mn) and Year-on-Year Growth, 2018-2034
Figure 35: Europe Market Absolute $ Opportunity Historical (2018-2023) and Forecast Period (2024-2034), US$ Mn
Figure 36: Europe Market Share, By End-user, 2024 & 2034
Figure 37: Europe Market Y-o-Y Growth Projections, By End-user – 2024-2034
Figure 38: Europe Market Attractiveness Index, By End-user – 2024-2034
Figure 39: Europe Market Share, By Application, 2024 & 2034
Figure 40: Europe Market Y-o-Y Growth Projections, By Application – 2024-2034
Figure 41: Europe Market Attractiveness Index, By Application – 2024-2034
Figure 42: Europe Market Share, By Country, 2024 & 2034
Figure 43: Europe Market Y-o-Y Growth Projections, By Country – 2024-2034
Figure 44: Europe Market Attractiveness Index, By Country – 2024-2034
Figure 45: MEA Market Value (US$ Mn) and Year-on-Year Growth, 2018-2034
Figure 46: MEA Market Absolute $ Opportunity Historical (2018-2023) and Forecast Period (2024-2034), US$ Mn
Figure 47: MEA Market Share, By End-user, 2024 & 2034
Figure 48: MEA Market Y-o-Y Growth Projections, By End-user – 2024-2034
Figure 49: MEA Market Attractiveness Index, By End-user – 2024-2034
Figure 50: MEA Market Share, By Application, 2024 & 2034
Figure 51: MEA Market Y-o-Y Growth Projections, By Application – 2024-2034
Figure 52: MEA Market Attractiveness Index, By Application – 2024-2034
Figure 53: MEA Market Share, By Country, 2024 & 2034
Figure 54: MEA Market Y-o-Y Growth Projections, By Country – 2024-2034
Figure 55: MEA Market Attractiveness Index, By Country – 2024-2034
Figure 56: Asia Pacific Market Value (US$ Mn) and Year-on-Year Growth, 2018-2034
Figure 57: Asia Pacific Market Absolute $ Opportunity Historical (2018-2023) and Forecast Period (2024-2034), US$ Mn
Figure 58: Asia Pacific Market Share, By End-user, 2024 & 2034
Figure 59: Asia Pacific Market Y-o-Y Growth Projections, By End-user – 2024-2034
Figure 60: Asia Pacific Market Attractiveness Index, By End-user – 2024-2034
Figure 61: Asia Pacific Market Share, By Application, 2024 & 2034
Figure 62: Asia Pacific Market Y-o-Y Growth Projections, By Application – 2024-2034
Figure 63: Asia Pacific Market Attractiveness Index, By Application – 2024-2034
Figure 64: Asia Pacific Market Share, By Country, 2024 & 2034
Figure 65: Asia Pacific Market Y-o-Y Growth Projections, By Country – 2024-2034
Figure 66: Asia Pacific Market Attractiveness Index, By Country – 2024-2034
Figure 67: US Market Value (US$ Mn) and Forecast, 2024-2034
Figure 68: US Market Share, By End-user, 2023
Figure 69: US Market Share, By Application, 2023
Figure 70: Canada Market Value (US$ Mn) and Forecast, 2024-2034
Figure 71: Canada Market Share, By End-user, 2023
Figure 72: Canada Market Share, By Application, 2023
Figure 73: Brazil Market Value (US$ Mn) and Forecast, 2024-2034
Figure 74: Brazil Market Share, By End-user, 2023
Figure 75: Brazil Market Share, By Application, 2023
Figure 76: Mexico Market Value (US$ Mn) and Forecast, 2024-2034
Figure 77: Mexico Market Share, By End-user, 2023
Figure 78: Mexico Market Share, By Application, 2023
Figure 79: Germany Market Value (US$ Mn) and Forecast, 2024-2034
Figure 80: Germany Market Share, By End-user, 2023
Figure 81: Germany Market Share, By Application, 2023
Figure 82: U.K. Market Value (US$ Mn) and Forecast, 2024-2034
Figure 83: U.K. Market Share, By End-user, 2023
Figure 84: U.K. Market Share, By Application, 2023
Figure 85: France Market Value (US$ Mn) and Forecast, 2024-2034
Figure 86: France Market Share, By End-user, 2023
Figure 87: France Market Share, By Application, 2023
Figure 88: Italy Market Value (US$ Mn) and Forecast, 2024-2034
Figure 89: Italy Market Share, By End-user, 2023
Figure 90: Italy Market Share, By Application, 2023
Figure 91: BENELUX Market Value (US$ Mn) and Forecast, 2024-2034
Figure 92: BENELUX Market Share, By End-user, 2023
Figure 93: BENELUX Market Share, By Application, 2023
Figure 94: Nordic Countries Market Value (US$ Mn) and Forecast, 2024-2034
Figure 95: Nordic Countries Market Share, By End-user, 2023
Figure 96: Nordic Countries Market Share, By Application, 2023
Figure 97: China Market Value (US$ Mn) and Forecast, 2024-2034
Figure 98: China Market Share, By End-user, 2023
Figure 99: China Market Share, By Application, 2023
Figure 100: Japan Market Value (US$ Mn) and Forecast, 2024-2034
Figure 101: Japan Market Share, By End-user, 2023
Figure 102: Japan Market Share, By Application, 2023
Figure 103: South Korea Market Value (US$ Mn) and Forecast, 2024-2034
Figure 104: South Korea Market Share, By End-user, 2023
Figure 105: South Korea Market Share, By Application, 2023
Figure 106: GCC Countries Market Value (US$ Mn) and Forecast, 2024-2034
Figure 107: GCC Countries Market Share, By End-user, 2023
Figure 108: GCC Countries Market Share, By Application, 2023
Figure 109: South Africa Market Value (US$ Mn) and Forecast, 2024-2034
Figure 110: South Africa Market Share, By End-user, 2023
Figure 111: South Africa Market Share, By Application, 2023
Figure 112: Turkey Market Value (US$ Mn) and Forecast, 2024-2034
Figure 113: Turkey Market Share, By End-user, 2023
Figure 114: Turkey Market Share, By Application, 2023
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How big is the market for digital therapeutics in 2024?
The global digital therapeutics market is valued at US$ 8 billion in 2024.
What is projected CAGR for the North American market through 2034?
The market in North America is expected to increase at 22.2% CAGR through 2034.
How is the East Asia market forecasted to grow?
The market in East Asia is forecasted to expand at 22.4% CAGR from 2024 to 2034.
How is the market expected to fare in South Korea?
The market in South Korea is forecasted to expand at 22.9% CAGR through 2024.
Which conditions account for high revenue generation from digital therapeutics?
Together, diabetes and obesity are projected to account for half of the global market share by 2034.
Digital Therapeutics Market